Peripheral blood cell‐free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|107|9|1329-1337

ISSN： 1347-9032

Source： Cancer Science, Vol.107, Iss.9, 2016-09, pp. : 1329-1337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1582-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 329-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

STX11 functions as a novel tumor suppressor gene in peripheral T‐cell lymphomas

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1455-1462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer immunotherapy using novel tumor‐associated antigenic peptides identified by genome‐wide cDNA microarray analyses

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 505-511

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

By  

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1722-1729

John Wiley & Sons Inc

Access to resources Recommend Favorite